FDA Approved: CRESEMBA — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approves Cresemba (isavuconazonium sulfate) under an original application for the treatment of invasive aspergillosis and mucormycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Mucormycosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

ORIG AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)